Personal tools

Coexpression cluster:C94: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C94_smallcell_adrenal_lung_nonsmall_small_somatostatinoma_teratocarcinoma |id=C94 }}")
 
No edit summary
Line 1: Line 1:
{{Coexpression_clusters
{{Coexpression_clusters
|full_id=C94_smallcell_adrenal_lung_nonsmall_small_somatostatinoma_teratocarcinoma
|full_id=C94_smallcell_adrenal_lung_nonsmall_small_somatostatinoma_teratocarcinoma
|gostat_on_coexpression_clusters=GO:0005737!cytoplasm!0.00283719973544866!9665;9245;796;5865;23705;64711;994;55536;4922;1785;10324;5126;10321;83658;79582;23499;5066;6480;64579;4249;23225;64374$GO:0030141!secretory granule!0.00283719973544866!5066;10321;5865$GO:0007189!G-protein signaling, adenylate cyclase activating pathway!0.00283719973544866!116;114131;796$GO:0044444!cytoplasmic part!0.00921918044552319!9665;5126;9245;10321;796;5865;64711;5066;6480;994;64579;23225;4922;4249;64374$GO:0000139!Golgi membrane!0.00921918044552319!9245;6480;64579;4249;64711$GO:0000267!cell fraction!0.00921918044552319!43849;116;9245;3757;4922;796;6338$GO:0005179!hormone activity!0.00921918044552319!116;114131;4922;796$GO:0007188!G-protein signaling, coupled to cAMP nucleotide second messenger!0.00921918044552319!116;114131;796$GO:0044431!Golgi apparatus part!0.00921918044552319!9245;6480;64579;4249;64711$GO:0019933!cAMP-mediated signaling!0.00921918044552319!116;114131;796$GO:0031410!cytoplasmic vesicle!0.00921918044552319!5126;5066;10321;4922;5865$GO:0031982!vesicle!0.00921918044552319!5126;5066;10321;4922;5865$GO:0005625!soluble fraction!0.00921918044552319!43849;116;4922;796$GO:0005794!Golgi apparatus!0.00921918044552319!5126;9245;6480;64579;4249;64711$GO:0007190!adenylate cyclase activation!0.0145487135589096!116;796$GO:0045087!innate immune response!0.0145487135589096!26280;10321;23705$GO:0007187!G-protein signaling, coupled to cyclic nucleotide second messenger!0.0145487135589096!116;114131;796$GO:0019935!cyclic-nucleotide-mediated signaling!0.0145487135589096!116;114131;796$GO:0051349!positive regulation of lyase activity!0.0145487135589096!116;796$GO:0045762!positive regulation of adenylate cyclase activity!0.0145487135589096!116;796$GO:0031281!positive regulation of cyclase activity!0.0145487135589096!116;796$GO:0005184!neuropeptide hormone activity!0.0194955752777347!116;4922$GO:0022402!cell cycle process!0.0194955752777347!116;994;23499;1785;23705$GO:0008015!blood circulation!0.0194955752777347!3757;4922;796$GO:0003013!circulatory system process!0.0194955752777347!3757;4922;796$GO:0006936!muscle contraction!0.0194955752777347!3757;796;10324$GO:0003012!muscle system process!0.0194955752777347!3757;796;10324$GO:0045761!regulation of adenylate cyclase activity!0.0194955752777347!116;796$GO:0042581!specific granule!0.0194955752777347!10321$GO:0004441!inositol-1,4-bisphosphate 1-phosphatase activity!0.0194955752777347!3628$GO:0048702!embryonic neurocranium morphogenesis!0.0194955752777347!7043$GO:0004598!peptidylamidoglycolate lyase activity!0.0194955752777347!5066$GO:0031716!calcitonin receptor binding!0.0194955752777347!796$GO:0004286!proprotein convertase 2 activity!0.0194955752777347!5126$GO:0001984!vasodilation of artery during baroreceptor response to increased systemic arterial blood pressure!0.0194955752777347!796$GO:0042271!susceptibility to natural killer cell mediated cytotoxicity!0.0194955752777347!23705$GO:0035150!regulation of tube size!0.0194955752777347!4922;796$GO:0050880!regulation of blood vessel size!0.0194955752777347!4922;796$GO:0051339!regulation of lyase activity!0.0194955752777347!116;796$GO:0031279!regulation of cyclase activity!0.0194955752777347!116;796$GO:0008016!regulation of heart contraction!0.0194955752777347!3757;796$GO:0003018!vascular process in circulatory system!0.0195443769341191!4922;796$GO:0006486!protein amino acid glycosylation!0.0195443769341191!9245;6480;4249$GO:0043413!biopolymer glycosylation!0.0200595991583854!9245;6480;4249$GO:0008375!acetylglucosaminyltransferase activity!0.0200900194078242!9245;4249$GO:0007154!cell communication!0.0200900194078242!116;5126;114131;81285;2059;796;5865;55160;3628;83661;26280;7043;3757;4922;1785$GO:0009101!glycoprotein biosynthetic process!0.0200900194078242!9245;6480;4249$GO:0003015!heart process!0.0200900194078242!3757;796$GO:0060047!heart contraction!0.0200900194078242!3757;796$GO:0012505!endomembrane system!0.0200900194078242!9245;6480;64579;23225;4249;64711$GO:0005102!receptor binding!0.0205864393041321!116;7043;114131;4922;796;23705$GO:0008146!sulfotransferase activity!0.0234886471417827!64579;64711$GO:0007165!signal transduction!0.0248165823120294!116;114131;81285;2059;796;5865;55160;3628;83661;26280;7043;3757;4922;1785$GO:0009100!glycoprotein metabolic process!0.0248165823120294!9245;6480;4249$GO:0051649!establishment of cellular localization!0.0248165823120294!7043;83658;23225;64374;5865;23705$GO:0043229!intracellular organelle!0.0248165823120294!9015;9665;9245;8431;796;5865;23705;64711;994;55536;4922;1785;10324;5126;10321;83658;23499;5066;6480;64579;23225;4249;64374$GO:0043226!organelle!0.0248165823120294!9015;9665;9245;8431;796;5865;23705;64711;994;55536;4922;1785;10324;5126;10321;83658;23499;5066;6480;64579;23225;4249;64374$GO:0006948!induction by virus of cell-cell fusion in host!0.0248165823120294!64711$GO:0004910!interleukin-1, Type II, blocking receptor activity!0.0248165823120294!26280$GO:0001983!baroreceptor response to increased systemic arterial blood pressure!0.0248165823120294!796$GO:0019968!interleukin-1, Type II, blocking binding!0.0248165823120294!26280$GO:0016312!inositol bisphosphate phosphatase activity!0.0248165823120294!3628$GO:0030144!alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase activity!0.0248165823120294!4249$GO:0051641!cellular localization!0.0248165823120294!7043;83658;23225;64374;5865;23705$GO:0048523!negative regulation of cellular process!0.025477497950714!116;7043;8431;23499;796;23705$GO:0031420!alkali metal ion binding!0.025477497950714!3628;3757;6338$GO:0016782!transferase activity, transferring sulfur-containing groups!0.0256829987908073!64579;64711$GO:0045786!negative regulation of progression through cell cycle!0.0256829987908073!116;23499;23705$GO:0048519!negative regulation of biological process!0.0292832235172398!116;7043;8431;23499;796;23705$GO:0065002!intracellular protein transport across a membrane!0.0301046166136714!23225;64374$GO:0007049!cell cycle!0.0301046166136714!116;994;23499;1785;23705$GO:0035313!wound healing, spreading of epidermal cells!0.0301046166136714!6338$GO:0004504!peptidylglycine monooxygenase activity!0.0301046166136714!5066$GO:0003829!beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity!0.0301046166136714!9245$GO:0016808!proprotein convertase activity!0.0301046166136714!5126$GO:0050961!detection of temperature stimulus during sensory perception!0.0301046166136714!796$GO:0050965!detection of temperature stimulus during sensory perception of pain!0.0301046166136714!796$GO:0045932!negative regulation of muscle contraction!0.0301046166136714!796$GO:0045986!negative regulation of smooth muscle contraction!0.0301046166136714!796$GO:0043085!positive regulation of catalytic activity!0.0309776874453533!116;7043;796$GO:0043065!positive regulation of apoptosis!0.0309776874453533!7043;1785;23705$GO:0043068!positive regulation of programmed cell death!0.031272145987102!7043;1785;23705$GO:0051606!detection of stimulus!0.0320111792065642!796;23705$GO:0019932!second-messenger-mediated signaling!0.0320111792065642!116;114131;796$GO:0035239!tube morphogenesis!0.0320111792065642!4922;796$GO:0002028!regulation of sodium ion transport!0.0320111792065642!6338$GO:0043195!terminal button!0.0320111792065642!796$GO:0033267!axon part!0.0320111792065642!796$GO:0016048!detection of temperature stimulus!0.0320111792065642!796$GO:0050951!sensory perception of temperature stimulus!0.0320111792065642!796$GO:0048701!embryonic cranial skeleton morphogenesis!0.0320111792065642!7043$GO:0003835!beta-galactoside alpha-2,6-sialyltransferase activity!0.0320111792065642!6480$GO:0007184!SMAD protein nuclear translocation!0.0320111792065642!7043$GO:0008109!N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity!0.0320111792065642!9245$GO:0003701!RNA polymerase I transcription factor activity!0.0320111792065642!9015$GO:0001978!carotid sinus baroreceptor feedback regulation of systemic arterial blood pressure!0.0320111792065642!796$GO:0003025!baroreceptor regulation of systemic arterial blood pressure!0.0320111792065642!796$GO:0031403!lithium ion binding!0.0320111792065642!3628$GO:0015016![heparan sulfate]-glucosamine N-sulfotransferase activity!0.0320111792065642!64579$GO:0016021!integral to membrane!0.0327749287978127!55365;9245;56654;199964;23705;64711;26280;3757;81285;6338;83661;5066;64579;6480;4249;23225$GO:0045184!establishment of protein localization!0.0342165106167176!7043;23225;64374;5865;23705$GO:0031224!intrinsic to membrane!0.0342165106167176!55365;9245;56654;199964;23705;64711;26280;3757;81285;6338;83661;5066;64579;6480;4249;23225$GO:0044464!cell part!0.0347920793349787!55365;796;55160;3757;994;55536;1785;5126;6338;5066;6480;64579;23225;4249;388743;64374;9015;9665;9245;56654;8431;5865;199964;23705;64711;26280;4922;10324;116;83658;10321;23499;81285;79582;43849;83661$GO:0006952!defense response!0.035617442548693!26280;10321;796;23705$GO:0008467!heparin-glucosamine 3-O-sulfotransferase activity!0.0369999458837642!64711$GO:0048265!response to pain!0.0369999458837642!796$GO:0003085!negative regulation of systemic arterial blood pressure!0.0369999458837642!796$GO:0008104!protein localization!0.038105327651986!7043;23225;64374;5865;23705$GO:0042995!cell projection!0.0401647866387421!79582;796;10324$GO:0030512!negative regulation of transforming growth factor beta receptor signaling pathway!0.0412863325297617!7043$GO:0002027!regulation of heart rate!0.0412863325297617!796$GO:0001912!positive regulation of leukocyte mediated cytotoxicity!0.0412863325297617!23705$GO:0051482!elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating)!0.0412863325297617!796$GO:0045954!positive regulation of natural killer cell mediated cytotoxicity!0.0412863325297617!23705$GO:0045778!positive regulation of ossification!0.0412863325297617!796$GO:0005856!cytoskeleton!0.0418085846115234!83658;994;23499;10324;1785;23705$GO:0050794!regulation of cellular process!0.0424296841742674!9015;116;8431;23499;796;5865;6338;23705;55160;7043;994;55536;3757;1785$GO:0007267!cell-cell signaling!0.042790728048361!116;5126;7043;796$GO:0033036!macromolecule localization!0.042790728048361!7043;23225;64374;5865;23705$GO:0051049!regulation of transport!0.04398091260169!5865;6338$GO:0042269!regulation of natural killer cell mediated cytotoxicity!0.0446444351479221!23705$GO:0031645!negative regulation of neurological process!0.0446444351479221!796$GO:0005868!cytoplasmic dynein complex!0.0446444351479221!83658$GO:0046852!positive regulation of bone remodeling!0.0446444351479221!796$GO:0016023!cytoplasmic membrane-bound vesicle!0.046404432021233!5066;10321;5865$GO:0035295!tube development!0.0471555423947684!4922;796$GO:0031988!membrane-bound vesicle!0.0473811370175228!5066;10321;5865$GO:0000074!regulation of progression through cell cycle!0.0473811370175228!116;23499;23705$GO:0048518!positive regulation of biological process!0.0473811370175228!7043;994;796;1785;23705$GO:0045776!negative regulation of blood pressure!0.0473811370175228!796$GO:0004908!interleukin-1 receptor activity!0.0473811370175228!26280$GO:0030279!negative regulation of ossification!0.0473811370175228!796$GO:0001976!regulation of systemic arterial blood pressure by neurological process!0.0473811370175228!796$GO:0051726!regulation of cell cycle!0.0473811370175228!116;23499;23705$GO:0005515!protein binding!0.0473811370175228!114131;8431;2059;796;5865;23705;26280;994;4922;1785;10324;116;5126;83658;6338;5066;7043;23225;64374$GO:0031090!organelle membrane!0.048147535383269!9245;6480;64579;23225;4249;64711$GO:0044425!membrane part!0.0491408776240159!55365;9245;56654;199964;23705;64711;26280;3757;1785;81285;6338;83661;5066;64579;6480;4249;23225
|id=C94
|id=C94
}}
}}

Revision as of 17:42, 18 May 2012


Full id: C94_smallcell_adrenal_lung_nonsmall_small_somatostatinoma_teratocarcinoma



Phase1 CAGE Peaks

Hg19::chr10:126027036..126027041,-p@chr10:126027036..126027041
-
Hg19::chr10:5407022..5407032,+p4@UCN3
Hg19::chr10:77056134..77056153,+p1@ZNF503-AS1
Hg19::chr10:77056181..77056190,+p2@ZNF503-AS1
Hg19::chr11:115158193..115158232,-p15@CADM1
Hg19::chr11:14992712..14992724,-p2@CALCA
Hg19::chr11:1643592..1643602,+p@chr11:1643592..1643602
+
Hg19::chr11:4718911..4718938,-p2@OR51E2
Hg19::chr11:4718944..4718953,-p4@OR51E2
Hg19::chr11:4719014..4719028,-p3@OR51E2
Hg19::chr11:4719072..4719089,-p1@OR51E2
Hg19::chr11:60467048..60467063,+p4@MS4A8B
Hg19::chr12:103353319..103353328,+p@chr12:103353319..103353328
+
Hg19::chr12:127992016..127992052,+p@chr12:127992016..127992052
+
Hg19::chr12:128077388..128077416,+p@chr12:128077388..128077416
+
Hg19::chr12:15784419..15784458,-p18@EPS8
Hg19::chr12:22852866..22852887,+p1@ENST00000536744
Hg19::chr12:23791058..23791099,+p@chr12:23791058..23791099
+
Hg19::chr12:50284871..50284904,-p@chr12:50284871..50284904
-
Hg19::chr12:86268065..86268080,+p1@NTS
Hg19::chr12:86272210..86272219,+p@chr12:86272210..86272219
+
Hg19::chr12:86272273..86272280,+p@chr12:86272273..86272280
+
Hg19::chr12:92401823..92401837,+p@chr12:92401823..92401837
+
Hg19::chr12:92401866..92401875,+p@chr12:92401866..92401875
+
Hg19::chr13:26619917..26619921,-p@chr13:26619917..26619921
-
Hg19::chr13:26626147..26626161,-p@chr13:26626147..26626161
-
Hg19::chr13:33498605..33498607,-p@chr13:33498605..33498607
-
Hg19::chr13:38508582..38508616,+p2@CR627261
Hg19::chr13:93329950..93329974,-p@chr13:93329950..93329974
-
Hg19::chr13:93372213..93372253,-p1@GPC5-AS1
Hg19::chr13:93372254..93372268,-p2@GPC5-AS1
Hg19::chr13:93372269..93372274,-p3@GPC5-AS1
Hg19::chr13:93372283..93372290,-p4@GPC5-AS1
Hg19::chr13:93439916..93439921,-p@chr13:93439916..93439921
-
Hg19::chr13:93508642..93508652,-p@chr13:93508642..93508652
-
Hg19::chr14:105637918..105637925,-p@chr14:105637918..105637925
-
Hg19::chr14:105643341..105643359,-p@chr14:105643341..105643359
-
Hg19::chr14:76278486..76278493,+p@chr14:76278486..76278493
+
Hg19::chr14:76447825..76447863,-p5@TGFB3
Hg19::chr15:51981498..51981513,+p@chr15:51981498..51981513
+
Hg19::chr15:51984388..51984400,+p6@SCG3
Hg19::chr15:59908653..59908680,+p4@GCNT3
Hg19::chr15:74528745..74528750,+p8@CCDC33
Hg19::chr15:74612015..74612053,-p@chr15:74612015..74612053
-
Hg19::chr16:1132642..1132649,-p@chr16:1132642..1132649
-
Hg19::chr16:1205163..1205193,+p@chr16:1205163..1205193
+
Hg19::chr16:12121188..12121212,+p@chr16:12121188..12121212
+
Hg19::chr16:15670786..15670791,-p@chr16:15670786..15670791
-
Hg19::chr16:15672837..15672851,+p@chr16:15672837..15672851
+
Hg19::chr16:15699973..15700008,-p10@KIAA0430
Hg19::chr16:1631093..1631103,-p@chr16:1631093..1631103
-
Hg19::chr16:1968408..1968425,-p1@HS3ST6
Hg19::chr16:23313614..23313629,+p2@SCNN1B
Hg19::chr16:23313645..23313671,+p1@SCNN1B
Hg19::chr16:71378536..71378548,-p@chr16:71378536..71378548
-
Hg19::chr16:735116..735143,-p@chr16:735116..735143
-
Hg19::chr17:1666131..1666142,+p@chr17:1666131..1666142
+
Hg19::chr18:56815532..56815544,+p@chr18:56815532..56815544
+
Hg19::chr18:56816249..56816258,+p@chr18:56816249..56816258
+
Hg19::chr18:56816267..56816276,+p@chr18:56816267..56816276
+
Hg19::chr18:56816796..56816816,+p@chr18:56816796..56816816
+
Hg19::chr18:56819783..56819803,+p@chr18:56819783..56819803
+
Hg19::chr18:56822974..56823004,-p@chr18:56822974..56823004
-
Hg19::chr18:71843121..71843138,+p@chr18:71843121..71843138
+
Hg19::chr18:71843159..71843180,+p@chr18:71843159..71843180
+
Hg19::chr18:904938..904986,+p2@ADCYAP1
Hg19::chr18:904994..905011,+p5@ADCYAP1
Hg19::chr18:905092..905103,+p12@ADCYAP1
Hg19::chr18:905104..905118,+p10@ADCYAP1
Hg19::chr19:10823418..10823430,+p15@DNM2
Hg19::chr19:10823451..10823463,+p10@DNM2
Hg19::chr19:10823464..10823473,+p16@DNM2
Hg19::chr19:3068219..3068225,-p@chr19:3068219..3068225
-
Hg19::chr19:42638173..42638181,+p1@ENST00000531517
Hg19::chr19:51537964..51537973,-p6@KLK12
Hg19::chr19:51537982..51537991,-p8@KLK12
Hg19::chr19:51538017..51538048,-p3@KLK12
Hg19::chr19:51538096..51538109,-p5@KLK12
Hg19::chr19:51538121..51538134,-p4@KLK12
Hg19::chr1:147084502..147084507,+p@chr1:147084502..147084507
+
Hg19::chr1:15416193..15416195,-p@chr1:15416193..15416195
-
Hg19::chr1:165198157..165198181,-p@chr1:165198157..165198181
-
Hg19::chr1:17906670..17906682,+p17@ARHGEF10L
Hg19::chr1:18807428..18807451,+p2@KLHDC7A
Hg19::chr1:188791401..188791408,-p@chr1:188791401..188791408
-
Hg19::chr1:209237425..209237437,-p@chr1:209237425..209237437
-
Hg19::chr1:222763113..222763144,-p3@TAF1A
Hg19::chr1:222763161..222763178,-p4@TAF1A
Hg19::chr1:223853355..223853378,-p2@CAPN8
Hg19::chr1:223853388..223853408,-p1@CAPN8
Hg19::chr1:223853431..223853436,-p4@CAPN8
Hg19::chr1:226067570..226067582,-p@chr1:226067570..226067582
-
Hg19::chr1:27240361..27240377,-p2@NR0B2
Hg19::chr1:39749767..39749791,+p17@MACF1
Hg19::chr1:52442908..52442917,-p9@RAB3B
Hg19::chr1:55446384..55446413,+p3@TMEM61
Hg19::chr20:10996541..10996543,+p@chr20:10996541..10996543
+
Hg19::chr20:17207711..17207722,+p3@PCSK2
Hg19::chr20:2310990..2310996,+p@chr20:2310990..2310996
+
Hg19::chr20:2311002..2311015,+p@chr20:2311002..2311015
+
Hg19::chr20:3184528..3184549,-p@chr20:3184528..3184549
-
Hg19::chr20:3184707..3184740,+p@chr20:3184707..3184740
+
Hg19::chr20:31958369..31958376,-p@chr20:31958369..31958376
-
Hg19::chr20:31958409..31958418,-p@chr20:31958409..31958418
-
Hg19::chr20:33114038..33114096,+p2@DYNLRB1
Hg19::chr20:3780693..3780714,+p17@CDC25B
Hg19::chr20:49241036..49241049,-p@chr20:49241036..49241049
-
Hg19::chr20:5896962..5896986,+p@chr20:5896962..5896986
+
Hg19::chr22:24251729..24251732,-p@chr22:24251729..24251732
-
Hg19::chr22:25297679..25297722,+p@chr22:25297679..25297722
+
Hg19::chr2:135011636..135011649,+p8@MGAT5
Hg19::chr2:163942394..163942398,+p@chr2:163942394..163942398
+
Hg19::chr2:170367210..170367234,+p6@KBTBD10
Hg19::chr2:191221240..191221253,+p17@INPP1
Hg19::chr2:214788522..214788538,+p2@SPAG16
Hg19::chr2:236414196..236414199,+p1@AGAP1-IT1
Hg19::chr2:2617159..2617172,-p@chr2:2617159..2617172
-
Hg19::chr2:99758223..99758246,+p3@C2orf15
p6@MRPL30
Hg19::chr3:129813701..129813712,+p@chr3:129813701..129813712
+
Hg19::chr3:13369325..13369334,-p6@NUP210
Hg19::chr3:148994474..148994479,-p1@CPHL1P
Hg19::chr3:176474114..176474132,-p@chr3:176474114..176474132
-
Hg19::chr3:186713943..186713982,+p35@ST6GAL1
Hg19::chr3:20038294..20038297,+p1@ENST00000364675
Hg19::chr3:55328211..55328214,+p@chr3:55328211..55328214
+
Hg19::chr3:55361260..55361286,-p@chr3:55361260..55361286
-
Hg19::chr4:10736435..10736454,-p@chr4:10736435..10736454
-
Hg19::chr4:10736455..10736475,-p@chr4:10736455..10736475
-
Hg19::chr4:10736487..10736498,-p@chr4:10736487..10736498
-
Hg19::chr4:114880636..114880650,+p@chr4:114880636..114880650
+
Hg19::chr4:116034768..116034781,-p2@NDST4
Hg19::chr4:144354723..144354734,+p@chr4:144354723..144354734
+
Hg19::chr4:156364770..156364801,+p@chr4:156364770..156364801
+
Hg19::chr5:102143765..102143784,+p22@PAM
Hg19::chr5:102143805..102143822,+p13@PAM
Hg19::chr5:102143830..102143844,+p18@PAM
Hg19::chr5:102143863..102143874,+p23@PAM
Hg19::chr5:125800836..125800850,+p21@GRAMD3
Hg19::chr5:138429594..138429616,-p7@SIL1
Hg19::chr5:15902227..15902252,-p@chr5:15902227..15902252
-
Hg19::chr5:40415240..40415245,+p@chr5:40415240..40415245
+
Hg19::chr5:54157..54174,+p@chr5:54157..54174
+
Hg19::chr6:132980317..132980326,-p@chr6:132980317..132980326
-
Hg19::chr6:132980338..132980346,-p@chr6:132980338..132980346
-
Hg19::chr6:24980950..24980956,+p@chr6:24980950..24980956
+
Hg19::chr6:32134832..32134862,+p11@EGFL8
Hg19::chr6:41168871..41168911,-p1@TREML2
Hg19::chr6:41168920..41168927,-p4@TREML2
Hg19::chr6:48219854..48219891,-p@chr6:48219854..48219891
-
Hg19::chr6:49695621..49695625,-p@chr6:49695621..49695625
-
Hg19::chr6:49696401..49696408,-p@chr6:49696401..49696408
-
Hg19::chr6:49701451..49701462,-p@chr6:49701451..49701462
-
Hg19::chr6:49712072..49712087,-p2@CRISP3
Hg19::chr7:100816687..100816697,-p4@NAT16
Hg19::chr7:130600779..130600797,+p@chr7:130600779..130600797
+
Hg19::chr7:130600802..130600814,+p@chr7:130600802..130600814
+
Hg19::chr7:150499243..150499249,-p@chr7:150499243..150499249
-
Hg19::chr7:150499392..150499424,-p@chr7:150499392..150499424
-
Hg19::chr7:150499428..150499436,-p@chr7:150499428..150499436
-
Hg19::chr7:150499437..150499449,-p@chr7:150499437..150499449
-
Hg19::chr7:150500070..150500081,+p27@TMEM176A
Hg19::chr7:150500286..150500288,-p@chr7:150500286..150500288
-
Hg19::chr7:150500382..150500396,+p9@TMEM176A
Hg19::chr7:150500441..150500448,+p34@TMEM176A
Hg19::chr7:150675342..150675363,-p4@KCNH2
Hg19::chr7:150675372..150675417,-p1@KCNH2
Hg19::chr7:21985656..21985667,-p3@CDCA7L
Hg19::chr7:26415673..26415697,-p@chr7:26415673..26415697
-
Hg19::chr7:26578438..26578451,-p2@KIAA0087
Hg19::chr7:26578466..26578485,-p1@KIAA0087
Hg19::chr7:27191798..27191816,-p@chr7:27191798..27191816
-
Hg19::chr7:29971838..29971870,-p@chr7:29971838..29971870
-
Hg19::chr7:36327304..36327316,+p11@EEPD1
Hg19::chr7:36327318..36327333,+p14@EEPD1
Hg19::chr7:872107..872145,+p2@SUN1
Hg19::chr7:92300854..92300857,-p@chr7:92300854..92300857
-
Hg19::chr7:92300908..92300913,-p@chr7:92300908..92300913
-
Hg19::chr7:99541928..99541935,-p@chr7:99541928..99541935
-
Hg19::chr8:10122760..10122784,+p@chr8:10122760..10122784
+
Hg19::chr8:104148509..104148517,+p@chr8:104148509..104148517
+
Hg19::chr8:125183765..125183776,-p1@ENST00000520031
p1@uc003yqy.1
Hg19::chr8:139856402..139856426,-p@chr8:139856402..139856426
-
Hg19::chr8:141018634..141018657,-p6@TRAPPC9
Hg19::chr8:141018664..141018674,-p15@TRAPPC9
Hg19::chr8:2104622..2104638,+p2@ENST00000518316
Hg19::chr8:29592736..29592744,-p3@C8orf75
Hg19::chr9:130738884..130738902,-p@chr9:130738884..130738902
-
Hg19::chr9:130738905..130738929,-p@chr9:130738905..130738929
-
Hg19::chr9:133816046..133816048,-p@chr9:133816046..133816048
-
Hg19::chr9:133816054..133816060,-p@chr9:133816054..133816060
-
Hg19::chr9:133816065..133816079,-p@chr9:133816065..133816079
-
Hg19::chr9:133816081..133816105,-p@chr9:133816081..133816105
-
Hg19::chr9:136467523..136467541,-p@chr9:136467523..136467541
-
Hg19::chr9:136499577..136499584,+p@chr9:136499577..136499584
+
Hg19::chr9:136753424..136753441,-p@chr9:136753424..136753441
-
Hg19::chr9:139940990..139941047,-p4@NPDC1
Hg19::chrX:103810874..103810885,+p1@IL1RAPL2
Hg19::chrX:104100378..104100381,+p@chrX:104100378..104100381
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0005737cytoplasm0.00283719973544866
GO:0030141secretory granule0.00283719973544866
GO:0007189G-protein signaling, adenylate cyclase activating pathway0.00283719973544866
GO:0044444cytoplasmic part0.00921918044552319
GO:0000139Golgi membrane0.00921918044552319
GO:0000267cell fraction0.00921918044552319
GO:0005179hormone activity0.00921918044552319
GO:0007188G-protein signaling, coupled to cAMP nucleotide second messenger0.00921918044552319
GO:0044431Golgi apparatus part0.00921918044552319
GO:0019933cAMP-mediated signaling0.00921918044552319
GO:0031410cytoplasmic vesicle0.00921918044552319
GO:0031982vesicle0.00921918044552319
GO:0005625soluble fraction0.00921918044552319
GO:0005794Golgi apparatus0.00921918044552319
GO:0007190adenylate cyclase activation0.0145487135589096
GO:0045087innate immune response0.0145487135589096
GO:0007187G-protein signaling, coupled to cyclic nucleotide second messenger0.0145487135589096
GO:0019935cyclic-nucleotide-mediated signaling0.0145487135589096
GO:0051349positive regulation of lyase activity0.0145487135589096
GO:0045762positive regulation of adenylate cyclase activity0.0145487135589096
GO:0031281positive regulation of cyclase activity0.0145487135589096
GO:0005184neuropeptide hormone activity0.0194955752777347
GO:0022402cell cycle process0.0194955752777347
GO:0008015blood circulation0.0194955752777347
GO:0003013circulatory system process0.0194955752777347
GO:0006936muscle contraction0.0194955752777347
GO:0003012muscle system process0.0194955752777347
GO:0045761regulation of adenylate cyclase activity0.0194955752777347
GO:0042581specific granule0.0194955752777347
GO:0004441inositol-1,4-bisphosphate 1-phosphatase activity0.0194955752777347
GO:0048702embryonic neurocranium morphogenesis0.0194955752777347
GO:0004598peptidylamidoglycolate lyase activity0.0194955752777347
GO:0031716calcitonin receptor binding0.0194955752777347
GO:0004286proprotein convertase 2 activity0.0194955752777347
GO:0001984vasodilation of artery during baroreceptor response to increased systemic arterial blood pressure0.0194955752777347
GO:0042271susceptibility to natural killer cell mediated cytotoxicity0.0194955752777347
GO:0035150regulation of tube size0.0194955752777347
GO:0050880regulation of blood vessel size0.0194955752777347
GO:0051339regulation of lyase activity0.0194955752777347
GO:0031279regulation of cyclase activity0.0194955752777347
GO:0008016regulation of heart contraction0.0194955752777347
GO:0003018vascular process in circulatory system0.0195443769341191
GO:0006486protein amino acid glycosylation0.0195443769341191
GO:0043413biopolymer glycosylation0.0200595991583854
GO:0008375acetylglucosaminyltransferase activity0.0200900194078242
GO:0007154cell communication0.0200900194078242
GO:0009101glycoprotein biosynthetic process0.0200900194078242
GO:0003015heart process0.0200900194078242
GO:0060047heart contraction0.0200900194078242
GO:0012505endomembrane system0.0200900194078242
GO:0005102receptor binding0.0205864393041321
GO:0008146sulfotransferase activity0.0234886471417827
GO:0007165signal transduction0.0248165823120294
GO:0009100glycoprotein metabolic process0.0248165823120294
GO:0051649establishment of cellular localization0.0248165823120294
GO:0043229intracellular organelle0.0248165823120294
GO:0043226organelle0.0248165823120294
GO:0006948induction by virus of cell-cell fusion in host0.0248165823120294
GO:0004910interleukin-1, Type II, blocking receptor activity0.0248165823120294
GO:0001983baroreceptor response to increased systemic arterial blood pressure0.0248165823120294
GO:0019968interleukin-1, Type II, blocking binding0.0248165823120294
GO:0016312inositol bisphosphate phosphatase activity0.0248165823120294
GO:0030144alpha-1,6-mannosyl-glycoprotein 6-beta-N-acetylglucosaminyltransferase activity0.0248165823120294
GO:0051641cellular localization0.0248165823120294
GO:0048523negative regulation of cellular process0.025477497950714
GO:0031420alkali metal ion binding0.025477497950714
GO:0016782transferase activity, transferring sulfur-containing groups0.0256829987908073
GO:0045786negative regulation of progression through cell cycle0.0256829987908073
GO:0048519negative regulation of biological process0.0292832235172398
GO:0065002intracellular protein transport across a membrane0.0301046166136714
GO:0007049cell cycle0.0301046166136714
GO:0035313wound healing, spreading of epidermal cells0.0301046166136714
GO:0004504peptidylglycine monooxygenase activity0.0301046166136714
GO:0003829beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity0.0301046166136714
GO:0016808proprotein convertase activity0.0301046166136714
GO:0050961detection of temperature stimulus during sensory perception0.0301046166136714
GO:0050965detection of temperature stimulus during sensory perception of pain0.0301046166136714
GO:0045932negative regulation of muscle contraction0.0301046166136714
GO:0045986negative regulation of smooth muscle contraction0.0301046166136714
GO:0043085positive regulation of catalytic activity0.0309776874453533
GO:0043065positive regulation of apoptosis0.0309776874453533
GO:0043068positive regulation of programmed cell death0.031272145987102
GO:0051606detection of stimulus0.0320111792065642
GO:0019932second-messenger-mediated signaling0.0320111792065642
GO:0035239tube morphogenesis0.0320111792065642
GO:0002028regulation of sodium ion transport0.0320111792065642
GO:0043195terminal button0.0320111792065642
GO:0033267axon part0.0320111792065642
GO:0016048detection of temperature stimulus0.0320111792065642
GO:0050951sensory perception of temperature stimulus0.0320111792065642
GO:0048701embryonic cranial skeleton morphogenesis0.0320111792065642
GO:0003835beta-galactoside alpha-2,6-sialyltransferase activity0.0320111792065642
GO:0007184SMAD protein nuclear translocation0.0320111792065642
GO:0008109N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity0.0320111792065642
GO:0003701RNA polymerase I transcription factor activity0.0320111792065642
GO:0001978carotid sinus baroreceptor feedback regulation of systemic arterial blood pressure0.0320111792065642
GO:0003025baroreceptor regulation of systemic arterial blood pressure0.0320111792065642
GO:0031403lithium ion binding0.0320111792065642
GO:0015016[heparan sulfate]-glucosamine N-sulfotransferase activity0.0320111792065642
GO:0016021integral to membrane0.0327749287978127
GO:0045184establishment of protein localization0.0342165106167176
GO:0031224intrinsic to membrane0.0342165106167176
GO:0044464cell part0.0347920793349787
GO:0006952defense response0.035617442548693
GO:0008467heparin-glucosamine 3-O-sulfotransferase activity0.0369999458837642
GO:0048265response to pain0.0369999458837642
GO:0003085negative regulation of systemic arterial blood pressure0.0369999458837642
GO:0008104protein localization0.038105327651986
GO:0042995cell projection0.0401647866387421
GO:0030512negative regulation of transforming growth factor beta receptor signaling pathway0.0412863325297617
GO:0002027regulation of heart rate0.0412863325297617
GO:0001912positive regulation of leukocyte mediated cytotoxicity0.0412863325297617
GO:0051482elevation of cytosolic calcium ion concentration during G-protein signaling, coupled to IP3 second messenger (phospholipase C activating)0.0412863325297617
GO:0045954positive regulation of natural killer cell mediated cytotoxicity0.0412863325297617
GO:0045778positive regulation of ossification0.0412863325297617
GO:0005856cytoskeleton0.0418085846115234
GO:0050794regulation of cellular process0.0424296841742674
GO:0007267cell-cell signaling0.042790728048361
GO:0033036macromolecule localization0.042790728048361
GO:0051049regulation of transport0.04398091260169
GO:0042269regulation of natural killer cell mediated cytotoxicity0.0446444351479221
GO:0031645negative regulation of neurological process0.0446444351479221
GO:0005868cytoplasmic dynein complex0.0446444351479221
GO:0046852positive regulation of bone remodeling0.0446444351479221
GO:0016023cytoplasmic membrane-bound vesicle0.046404432021233
GO:0035295tube development0.0471555423947684
GO:0031988membrane-bound vesicle0.0473811370175228
GO:0000074regulation of progression through cell cycle0.0473811370175228
GO:0048518positive regulation of biological process0.0473811370175228
GO:0045776negative regulation of blood pressure0.0473811370175228
GO:0004908interleukin-1 receptor activity0.0473811370175228
GO:0030279negative regulation of ossification0.0473811370175228
GO:0001976regulation of systemic arterial blood pressure by neurological process0.0473811370175228
GO:0051726regulation of cell cycle0.0473811370175228
GO:0005515protein binding0.0473811370175228
GO:0031090organelle membrane0.048147535383269
GO:0044425membrane part0.0491408776240159



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C94&oldid=1703563"